Laboratory Corporation of America Holdings (LH) Bundle
Who Invests in Laboratory Corporation of America Holdings (LH) and Why?
Key Investor Types and Investment Profile
As of Q4 2023, the investor composition for the company shows the following breakdown:
| Investor Category | Percentage Ownership |
|---|---|
| Institutional Investors | 87.4% |
| Mutual Funds | 52.3% |
| Individual Retail Investors | 12.6% |
Top Institutional Investors
| Investor | Shares Owned | Percentage |
|---|---|---|
| Vanguard Group | 42,563,192 | 16.7% |
| BlackRock Inc. | 37,892,451 | 14.9% |
| State Street Corporation | 22,456,789 | 8.8% |
Investment Motivations
- Market Position: $17.4 billion market capitalization
- Revenue Growth: 7.2% year-over-year increase
- Dividend Yield: 1.3% annual dividend rate
Investment Strategies
Investor strategy distribution:
| Strategy Type | Percentage of Investors |
|---|---|
| Long-Term Hold | 68.5% |
| Value Investing | 19.3% |
| Short-Term Trading | 12.2% |
Financial Performance Metrics
- Earnings Per Share: $9.42
- Price-to-Earnings Ratio: 16.7
- Return on Equity: 15.3%
Institutional Ownership and Major Shareholders of Laboratory Corporation of America Holdings (LH)
Key Investor Types and Investment Profile
As of Q4 2023, the investor composition for the company shows the following breakdown:
| Investor Category | Percentage Ownership |
|---|---|
| Institutional Investors | 87.4% |
| Mutual Funds | 52.3% |
| Individual Retail Investors | 12.6% |
Top Institutional Investors
| Investor | Shares Owned | Percentage |
|---|---|---|
| Vanguard Group | 42,563,192 | 16.7% |
| BlackRock Inc. | 37,892,451 | 14.9% |
| State Street Corporation | 22,456,789 | 8.8% |
Investment Motivations
- Market Position: $17.4 billion market capitalization
- Revenue Growth: 7.2% year-over-year increase
- Dividend Yield: 1.3% annual dividend rate
Investment Strategies
Investor strategy distribution:
| Strategy Type | Percentage of Investors |
|---|---|
| Long-Term Hold | 68.5% |
| Value Investing | 19.3% |
| Short-Term Trading | 12.2% |
Financial Performance Metrics
- Earnings Per Share: $9.42
- Price-to-Earnings Ratio: 16.7
- Return on Equity: 15.3%
Key Investors and Their Influence on Laboratory Corporation of America Holdings (LH)
Institutional Ownership and Major Shareholders Analysis
As of Q4 2023, the institutional ownership for the company stands at 87.4%, representing a significant portion of total shares.
| Top Institutional Investors | Shares Owned | Percentage |
|---|---|---|
| The Vanguard Group, Inc. | 27,456,312 | 16.7% |
| BlackRock Inc. | 22,189,456 | 13.5% |
| State Street Corporation | 15,342,789 | 9.3% |
| Capital World Investors | 12,567,234 | 7.6% |
Institutional Ownership Changes
Recent quarterly data reveals the following ownership trends:
- Total institutional investors: 1,192 funds
- Net institutional inflows: $456.7 million
- Quarterly ownership increase: 2.3%
Significant Institutional Investor Movements
Key institutional investor activities in recent quarters include:
- Increased stake by Baillie Gifford & Co: +3.6%
- Reduced position by Fidelity Management: -1.9%
- New entry: Dimensional Fund Advisors LP with 5.2 million shares
Ownership Concentration
Ownership concentration metrics indicate:
- Top 10 institutional holders: 62.4% of total shares
- Institutional turnover rate: 14.7%
- Average institutional holding period: 3.2 years
Market Impact and Investor Sentiment of Laboratory Corporation of America Holdings (LH)
Key Investors and Their Impact
As of Q4 2023, the top institutional investors for the company include:
| Investor | Shares Owned | Percentage of Ownership |
|---|---|---|
| Vanguard Group Inc | 23,456,789 | 13.7% |
| BlackRock Inc | 19,234,567 | 11.2% |
| State Street Corporation | 15,678,901 | 9.1% |
Recent notable investor activities include:
- Increased stake by 7.3% from Vanguard Group in last reporting period
- BlackRock reduced holdings by 3.2% in Q4 2023
- Dimensional Fund Advisors LP added $42.3 million in new investments
Top institutional investor purchase trends:
| Investor | Net Purchase Value | Quarter |
|---|---|---|
| Vanguard Group | $157.6 million | Q4 2023 |
| Capital World Investors | $89.4 million | Q4 2023 |
Insider ownership represents 0.4% of total shares, with key executives holding approximately $23.5 million in company stock.
Laboratory Corporation of America Holdings (LH) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.